Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,123,124
-$274,159 QoQ
Shares Held
24,720
+1.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#707
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST FOUNDATION ADVISORS holds $34,560,047 across 8 Drug Manufacturers - General names. GILD ranks #4 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
47,126 | $11,968,589 | |
| 2 | LLY |
ELI LILLY & Co
|
5,869 | $7,039,455 | |
| 3 | AZN |
Astrazeneca PLC
|
18,550 | $3,517,450 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
24,720 | $3,123,124 | |
| 5 | PFE |
Pfizer Inc
|
121,118 | $2,916,521 | |
| 6 | ABBV |
AbbVie Inc.
|
10,123 | $2,547,351 | |
| 7 | MRK |
Merck & Co., Inc.
|
16,084 | $2,066,794 | |
| 8 | AMGN |
Amgen Inc
|
3,813 | $1,380,763 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,123,124 | 24,720 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,397,283 | 24,376 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,703,839 | 22,029 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $2,489,064 | 22,424 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $2,486,148 | 22,424 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,588,467 | 23,101 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,152,498 | 23,303 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,978,875 | 23,603 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,591,820 | 23,201 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $1,718,151 | 23,456 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,766,166 | 34,146 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,690,720 | 49,249 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $3,855,580 | 50,027 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,072,997 | 49,090 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,167,912 | 60,197 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,822,497 | 61,963 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,848,166 | 62,258 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,589,531 | 60,379 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $4,687,556 | 64,558 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,253,026 | 60,888 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,156,114 | 60,356 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,895,185 | 60,269 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $3,542,324 | 60,802 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,837,275 | 60,726 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $4,810,904 | 62,528 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,768,940 | 63,790 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||